Isabella Presch/LinkedIn, Ernest Amankwah/LinkedIn
Jul 18, 2026, 16:58
Isabella Presch: Innovative Trial Designs for Rare Pediatric Studies
Isabella Presch, Senior Medical Director Rare diseases, Advanced therapies and Pediatrics at Fortrea, shared a post on LinkedIn:
”Innovative study designs and analyses for rare pediatric studies International Society on Thrombosis and Haemostasis (ISTH)
Ernest Amankwah presented an innovative approach to add data from non randomized patients to the RCT design in rare pediatric conditions.”
Stay updated with Hemostasis Today.
-
Jul 19, 2026, 04:39Saoud Hassan: Identifying Monocytic Precursors Under the Microscope
-
Jul 19, 2026, 04:23Iris van Moort: Expert Insights on Pediatric Hemostasis Diagnostics at ISTH 2026
-
Jul 19, 2026, 04:09Er. Subodh Grewal: How Platelet Histograms Support Hematology Diagnosis
-
Jul 19, 2026, 03:53Serhii Pelishenko: Current Evidence on Kaolin and Chitosan Dressings
-
Jul 18, 2026, 23:52Chinua Onyebuchi: Applications Now Open for the European Stroke Master Programme
-
Jul 18, 2026, 22:43Exploring the Ultra-Late Window for Stroke Treatment – International Journal of Stroke
-
Jul 18, 2026, 21:38Swastik Sharma Deviprasad Bhat: A One-Minute Guide to Recognizing Stroke
-
Jul 18, 2026, 21:05Federica Fedele: From One-Size-Fits-All to Personalized Care
-
Jul 18, 2026, 21:04Sandra Rodríguez Coma: A Great Experience With the Werfen Team at ISTH 2026